Optimal allocation of gold standard testing under constrained availability: application to assessment of HIV treatment failure

From MaRDI portal
Publication:5406342

DOI10.1080/01621459.2013.810149zbMATH Open1288.62163arXiv2010.00692OpenAlexW3105420601WikidataQ37658177 ScholiaQ37658177MaRDI QIDQ5406342FDOQ5406342


Authors: Tao Liu, Joseph W. Hogan, Lisa Wang, Shangxuan Zhang, Rami Kantor Edit this on Wikidata


Publication date: 1 April 2014

Published in: Journal of the American Statistical Association (Search for Journal in Brave)

Abstract: The World Health Organization (WHO) guidelines for monitoring the effectiveness of HIV treatment in resource-limited settings (RLS) are mostly based on clinical and immunological markers (e.g., CD4 cell counts). Recent research indicates that the guidelines are inadequate and can result in high error rates. Viral load (VL) is considered the "gold standard", yet its widespread use is limited by cost and infrastructure. In this paper, we propose a diagnostic algorithm that uses information from routinely-collected clinical and immunological markers to guide a selective use of VL testing for diagnosing HIV treatment failure, under the assumption that VL testing is available only at a certain portion of patient visits. Our algorithm identifies the patient subpopulation, such that the use of limited VL testing on them minimizes a pre-defined risk (e.g., misdiagnosis error rate). Diagnostic properties of our proposal algorithm are assessed by simulations. For illustration, data from the Miriam Hospital Immunology Clinic (RI, USA) are analyzed.


Full work available at URL: https://arxiv.org/abs/2010.00692




Recommendations




Cites Work


Cited In (1)

Uses Software





This page was built for publication: Optimal allocation of gold standard testing under constrained availability: application to assessment of HIV treatment failure

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5406342)